Orbital and periocular complications in patients with sinonasal tumours with orbital invasion.

Eye Lids Lacrimal drainage Neoplasia Orbit

Journal

The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041

Informations de publication

Date de publication:
27 Jan 2023
Historique:
received: 02 11 2022
accepted: 14 01 2023
pmc-release: 27 07 2024
entrez: 27 1 2023
pubmed: 28 1 2023
medline: 28 1 2023
Statut: aheadofprint

Résumé

The purpose of this study was to determine the frequency and associated risk factors of orbital/periocular complications in patients with sinonasal tumour with orbital invasion managed with eye-sparing treatments. A retrospective case series of patients with primary sinonasal tumour with orbital invasion from January 2008 to December 2018. Patient factors were compared between the following groups: (1)patients with orbital/periocular complications versus those who did not and (2) patients who needed secondary oculoplastic surgical procedures versus those who did not. Out of 80 patients, 48 had eye-sparing surgery, 8 had orbital exenteration and 24 were managed non-surgically. The most common histology was squamous cell carcinoma (n=28, 35%). Among the eye-sparing treatment group, 51/72 patients experienced one or more orbital/periocular complication(s), with motility deficit (N=26, 36%) being the most frequent. Factors associated with higher risk of complications included tumour involving the orbital floor (p=0.019), clinical disease stage III/IV (p=0.038), maxillectomy (p=0.004), resection of the orbital floor (p=0.027) and cigarette smoking (p=0.041). Tumour involving the orbital floor had an OR of 3.9 (95% CI 1.3 to 11.6, p=0.016) in predicting orbital/periocular complication. In the eye-sparing surgery group, the most frequent secondary oculoplastic procedures was dacryocystorhinostomy (n=6, 13%). The use of a free flap in reconstruction had an OR of 8.2 (95% CI 2.1 to 31.8, p=0.002) in predicting need for secondary oculoplastic surgery. Majority of patients with sinonasal tumours and secondary orbital invasion were managed with eye-sparing multidisciplinary treatments. Preservation of the eye can lead to reasonably good functional outcome despite expected orbital and periocular complications.

Identifiants

pubmed: 36707226
pii: bjo-2022-322855
doi: 10.1136/bjo-2022-322855
pmc: PMC10372198
mid: NIHMS1869058
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Clin J Oncol Nurs. 2012 Apr;16(2):153-9
pubmed: 22459524
Otolaryngol Head Neck Surg. 1993 Jul;109(1):111-5
pubmed: 8336956
J Neurol Surg B Skull Base. 2015 Mar;76(2):122-8
pubmed: 25844298
Am J Surg. 1973 Oct;126(4):469-76
pubmed: 4743833
Int J Oral Maxillofac Surg. 2014 Jan;43(1):1-6
pubmed: 23958462
Int Forum Allergy Rhinol. 2020 Feb;10(2):243-255
pubmed: 31756058
Head Neck. 2006 Oct;28(10):867-73
pubmed: 16823871
Ophthalmic Plast Reconstr Surg. 2010 Jan-Feb;26(1):18-22
pubmed: 20090478
ORL J Otorhinolaryngol Relat Spec. 1983;45(1):1-12
pubmed: 6828310
Head Neck. 2005 Jul;27(7):575-84
pubmed: 15825201
Head Neck. 2019 Aug;41(8):2777-2788
pubmed: 30932253
Head Neck. 2013 Oct;35(10):1379-84
pubmed: 22972502
Curr Opin Otolaryngol Head Neck Surg. 2022 Apr 1;30(2):125-129
pubmed: 35255049
J Laryngol Otol. 1976 Jan;90(1):69-74
pubmed: 1255006
Head Neck. 2016 Nov;38(11):1650-1656
pubmed: 27131342
Laryngoscope. 1999 Feb;109(2 Pt 1):230-5
pubmed: 10890772
Ophthalmic Plast Reconstr Surg. 2022 Jan-Feb 01;38(1):29-33
pubmed: 33782330
Am J Rhinol. 2004 Jul-Aug;18(4):233-8
pubmed: 15490570
Head Neck. 2008 Feb;30(2):242-50
pubmed: 18023029
Cancer. 2000 Nov 1;89(9):1925-32
pubmed: 11064349
Laryngoscope. 2002 Aug;112(8 Pt 1):1357-65
pubmed: 12172245

Auteurs

Jiawei Zhao (J)

Orbital Oncology & Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Xinyang Jiang (X)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Ehab Hanna (E)

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Shirley Y Su (SY)

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Amy Moreno (A)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Brandon Gunn (B)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Steven Jay Frank (SJ)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Renata Ferrarotto (R)

Department of Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Jing Ning (J)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Bita Esmaeli (B)

Orbital Oncology & Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA besmaeli@mdanderson.org.

Classifications MeSH